atenolol has been researched along with Chromosomal Fragility in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Télez, M | 1 |
| Ortiz-Lastra, E | 1 |
| Gonzalez, AJ | 1 |
| Flores, P | 1 |
| Huerta, I | 1 |
| Ramírez, JM | 1 |
| Barasoain, M | 1 |
| Criado, B | 1 |
| Arrieta, I | 1 |
1 other study available for atenolol and Chromosomal Fragility
| Article | Year |
|---|---|
Assessment of the genotoxicity of atenolol in human peripheral blood lymphocytes: correlation between chromosomal fragility and content of micronuclei.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Case-Control Studies; Chromosome Fragile Sites; Chro | 2010 |